A "Shock and Awe" Acquisition
Motley Fool Money
00:00
Johnson & Johnson's $16.6 Billion Acquisition
This chapter examines Johnson & Johnson's major acquisition of Abiomed, a heart pump manufacturer, for $16.6 billion, highlighting the strategic implications for J&J's medical device division. The discussion delves into the potential growth of Abiomed's products and the deal's significance amidst the company's upcoming operational split.
Transcript
Play full episode
